|
... subject to customary adjustments, consists of Conduent's workers' compensation and auto casualty bill review solutions and services that includes the processing of medical bills and clinical ...
01Net
-
4-5-2024
|
|
|
|
It draws on more than 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier, and optimize the effectiveness of ...
01Net
-
3-5-2024
|
|
|
|
Kerrie Woods, Director, R&D Clinical Informatics for OUH commented: 'Arcturis has unique expertise in integrating molecular and clinical data and curating fit - for - purpose regulatory - grade ...
01Net
-
3-5-2024
|
|
|
|
... including TPS Dose Comparison and Live Scan QA functionalities, allow users faster understanding of treatment planning system model accuracy and saves time by proactively warning clinical users if ...
01Net
-
3-5-2024
|
|
|
|
(NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of ...
01Net
-
2-5-2024
|
|
|
|
About Myonex Myonex is a leading global complete clinical trial supply company offering tailored solutions in central and local drug sourcing, packaging, labeling, and ancillary and equipment supply ...
Adnkronos
-
2-5-2024
|
|
|
|
About Omnicell Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes - centric innovation designed to optimize clinical and business outcomes across all settings of ...
01Net
-
2-5-2024
|
|
|
|
...and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials Business Wire Business Wire - 2 Maggio 2024 Joint collaborations bring Boehringer Ingelheim's Phase III clinical trial ...
01Net
-
2-5-2024
|
|
|
|
It's a step forward in transforming the landscape of clinical research, helping to make clinical trials more inclusive and accessible.' Additionally, Boehringer is partnering with EmVenio Research to ...
01Net
-
2-5-2024
|
|
|
|
... estimates regarding the development timing for our drug candidates and ADC development program; expectations and estimates regarding clinical trial timing and patient enrollment; our research and ...
01Net
-
2-5-2024
|
|
|
